Compare Alcon AG (ALC) vs Las Vegas Sands Corp. (LVS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Alcon AG vs Las Vegas Sands Corp. — how do they compare? Alcon AG trades at $66.89 (market cap $32.69B), while Las Vegas Sands Corp. trades at $46.66 (market cap $30.52B). The key difference: Alcon AG and Las Vegas Sands Corp. are close in size by market cap, and Las Vegas Sands Corp. pays the higher dividend (2.39%). Which is the better fit depends on your goals.
| ALC | LVS | |
|---|---|---|
Market Cap | $32.69B | $30.52B |
Sector | Health | Consumer Cyclical |
52-Week High | $92.22 | $69.49 |
52-Week Low | $62.02 | $46.06 |
Enterprise Value | $36.28B | $42.92B |
Dividend Yield | 0.54% | 2.39% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
LVS trades at $46.06, down 1.98% on the day, amid a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.91 exceeding expectations, and maintains robust profitability with a net income margin of 13.41%. Recent news highlights ESG achievements and Macao's economic diversification efforts. Cash flow trends show positive net cash flow in 2025 after previous years of outflows.
The outlook for LVS is supported by solid fundamentals and analyst optimism, with a consensus price target of $66.38 implying significant upside. Risks include high debt levels, with a debt-to-asset ratio of 73.15% in 2025, and exposure to Macao's regulatory environment. Institutional sentiment remains positive, with no sell ratings among 49 analysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Las Vegas Sands Corp.
Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner, Four Seasons Hotel Macao, and Parisian in Macao, and the Marina Bay Sands resort in Singapore. Its Venetian and Palazzo Las Vegas in the U.S. asets were sold to Apollo and VICI for $6.25 billion in 2022. We expect Sands to open a fourth tower in Singapore in 2026. After the sale of its Vegas assets, the company will generate all its EBITDA from Asia, with its casino operations generating the majority of sales.
Read more on LVS →
